These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 12621387)

  • 1. P-glycoprotein-mediated intestinal and biliary digoxin transport in humans.
    Drescher S; Glaeser H; Mürdter T; Hitzl M; Eichelbaum M; Fromm MF
    Clin Pharmacol Ther; 2003 Mar; 73(3):223-31. PubMed ID: 12621387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased absorption of digoxin from the human jejunum due to inhibition of intestinal transporter-mediated efflux.
    Igel S; Drescher S; Mürdter T; Hofmann U; Heinkele G; Tegude H; Glaeser H; Brenner SS; Somogyi AA; Omari T; Schäfer C; Eichelbaum M; Fromm MF
    Clin Pharmacokinet; 2007; 46(9):777-85. PubMed ID: 17713975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein.
    Westphal K; Weinbrenner A; Giessmann T; Stuhr M; Franke G; Zschiesche M; Oertel R; Terhaag B; Kroemer HK; Siegmund W
    Clin Pharmacol Ther; 2000 Jul; 68(1):6-12. PubMed ID: 10945310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interaction.
    Westphal K; Weinbrenner A; Zschiesche M; Franke G; Knoke M; Oertel R; Fritz P; von Richter O; Warzok R; Hachenberg T; Kauffmann HM; Schrenk D; Terhaag B; Kroemer HK; Siegmund W
    Clin Pharmacol Ther; 2000 Oct; 68(4):345-55. PubMed ID: 11061574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin.
    Greiner B; Eichelbaum M; Fritz P; Kreichgauer HP; von Richter O; Zundler J; Kroemer HK
    J Clin Invest; 1999 Jul; 104(2):147-53. PubMed ID: 10411543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the intestinal digoxin absorption and exsorption by quinidine.
    Su SF; Huang JD
    Drug Metab Dispos; 1996 Feb; 24(2):142-7. PubMed ID: 8742224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of recombinant interleukin-2 pretreatment on oral and intravenous digoxin pharmacokinetics and P-glycoprotein activity in mice.
    Castagne V; Bonhomme-Faivre L; Urien S; Ben Reguiga M; Soursac M; Gimenez F; Farinotti R
    Drug Metab Dispos; 2004 Feb; 32(2):168-71. PubMed ID: 14744937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of interferon-gamma on the pharmacokinetics of digoxin, a P-glycoprotein substrate, intravenously injected into the mouse.
    Kawaguchi H; Matsui Y; Watanabe Y; Takakura Y
    J Pharmacol Exp Ther; 2004 Jan; 308(1):91-6. PubMed ID: 14569074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine.
    Kharasch ED; Hoffer C; Whittington D; Sheffels P
    Clin Pharmacol Ther; 2003 Dec; 74(6):543-54. PubMed ID: 14663457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro P-glycoprotein interactions and steady-state pharmacokinetic interactions between tolvaptan and digoxin in healthy subjects.
    Shoaf SE; Ohzone Y; Ninomiya S; Furukawa M; Bricmont P; Kashiyama E; Mallikaarjun S
    J Clin Pharmacol; 2011 May; 51(5):761-9. PubMed ID: 20679500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinidine as a probe for the role of p-glycoprotein in the intestinal absorption and clinical effects of fentanyl.
    Kharasch ED; Hoffer C; Altuntas TG; Whittington D
    J Clin Pharmacol; 2004 Mar; 44(3):224-33. PubMed ID: 14973303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-glycoprotein and an unstirred water layer barring digoxin absorption in the vascularly perfused rat small intestine preparation: induction studies with pregnenolone-16alpha-carbonitrile.
    Liu S; Tam D; Chen X; Pang KS
    Drug Metab Dispos; 2006 Sep; 34(9):1468-79. PubMed ID: 16751264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of rat intestinal P-glycoprotein by spironolactone and its effect on absorption of orally administered digoxin.
    Ghanem CI; Gómez PC; Arana MC; Perassolo M; Delli Carpini G; Luquita MG; Veggi LM; Catania VA; Bengochea LA; Mottino AD
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1146-52. PubMed ID: 16740618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of in vivo absorption, metabolism, and transport of drugs by the human intestinal wall and liver with a novel perfusion technique.
    von Richter O; Greiner B; Fromm MF; Fraser R; Omari T; Barclay ML; Dent J; Somogyi AA; Eichelbaum M
    Clin Pharmacol Ther; 2001 Sep; 70(3):217-27. PubMed ID: 11557909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of in vitro data in making accurate predictions of human P-glycoprotein-mediated drug-drug interactions: a case study for AZD5672.
    Elsby R; Gillen M; Butters C; Imisson G; Sharma P; Smith V; Surry DD
    Drug Metab Dispos; 2011 Feb; 39(2):275-82. PubMed ID: 21075975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex situ inhibition of hepatic uptake and efflux significantly changes metabolism: hepatic enzyme-transporter interplay.
    Lau YY; Wu CY; Okochi H; Benet LZ
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1040-5. PubMed ID: 14634033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human intestinal P-glycoprotein activity estimated by the model substrate digoxin.
    Larsen UL; Hyldahl Olesen L; Guldborg Nyvold C; Eriksen J; Jakobsen P; Østergaard M; Autrup H; Andersen V
    Scand J Clin Lab Invest; 2007; 67(2):123-34. PubMed ID: 17365992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers.
    Ding R; Tayrouz Y; Riedel KD; Burhenne J; Weiss J; Mikus G; Haefeli WE
    Clin Pharmacol Ther; 2004 Jul; 76(1):73-84. PubMed ID: 15229466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of various cytochrome P450 3A and P-glycoprotein modulators on the biliary clearance of bromosulphaphthalein in male wistar rats.
    Machavaram KK; Gundu J; Yamsani MR
    Pharmazie; 2004 Dec; 59(12):957-60. PubMed ID: 15638086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.